Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
U-Liang Pharmaceutical is a Taiwan-based pharmaceutical manufacturer focused on commercialized products rather than a novel-drug clinical pipeline. The company manufactures and sells human pharmaceuticals, animal drugs, medical devices, cosmetics, and related healthcare products, and it operates a production site in Hukou Township, Hsinchu County. Available sources indicate that U-Liang was founded in 1978 and remains active as an operating company. It appears to have been acquired into the Synmosa Group around 2013, and Synmosa later described U-Liang as one of the pharmaceutical companies it had merged with as part of its manufacturing and product portfolio expansion. The business is best characterized as a commercial specialty/generics and manufacturing company with PIC/S GMP-aligned operations rather than a development-stage biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on U-Liang Pharmaceutical.